taking too much semaglutide Common And Rare Side Effects Of For Weight Loss People Are Overdosing on Semaglutide

Semaglutide (Wegovy, Ozempic) received FDA approval for chronic weight management in 2021, followed by tirzepatide (Zepbound) in 2023, both demonstrating substantial weight loss in clinical trials

It is not recommended to use Wegovy or Ozempic while pregnant

L.GolskiS.McPhieD

The drugs ability to decrease intake and preference for rewarding foods suggests a broader suppressive effect on motivation for rewards, which may be beneficial for individuals with addictive behaviors beyond alcohol. Drinking alcohol is common in many cultures and countries

Furthermore, it slows gastric emptying, which reduces postprandial glucose excursionsa critical factor for the 4.3 million people in the UK living with type 2 diabetes